Sorafenib-induced acute pancreatitis

Sorafenib-induced acute pancreatitis

Sorafenib was approved in 2005 for the treatment of metastatic renal cell carcinoma and advanced hepatocellular carcinoma (HCC). Acute pancreatitis is a side-effect of sorafenib usage. We present a patient with advanced HCC who presented with acute Grade D pancreatitis caused by sorafenib administra...

Full description

Bibliographic Details
Main Authors: Han-En Wang, Chun-Ting Chen, Hsin-Hung Huang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Journal of Medical Sciences
Subjects:
Sorafenib
pancreatitis
hepatocellular carcinoma
Online Access:http://jms.ndmctsgh.edu.tw/article.asp?issn=1011-4564;year=2014;volume=34;issue=3;spage=126;epage=128;aulast=Wang

Internet

http://jms.ndmctsgh.edu.tw/article.asp?issn=1011-4564;year=2014;volume=34;issue=3;spage=126;epage=128;aulast=Wang

Similar Items